Ziekenhuis Amstelland

Research at this hospital in Cardiology focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease, atrial fibrillation, and broader outcomes linked to heart and vascular risk. The trials are designed to test new treatment strategies, improve prevention, and evaluate whether therapies can reduce major events such as heart attack, stroke, and cardiovascular death.

• ASCVD prevention and reduction of major cardiovascular events
• Atrial fibrillation and stroke prevention after acute stress-related episodes
• Cardiovascular risk reduction in people with type 2 diabetes or overweight

Several studies also examine whether newer medicines can improve long-term heart and vascular outcomes when added to standard care.

The site is active in oncology research across several neoplasms, including breast cancer, metastatic colorectal cancer, and diffuse large B-cell lymphoma. These trials aim to refine treatment choices, explore treatment de-escalation where appropriate, and assess whether targeted or immune-based approaches can improve outcomes for people with difficult-to-treat cancers.

• Breast cancer, including triple negative breast cancer and HR-positive, HER2-negative disease
• Metastatic colorectal cancer and treatment intensity optimization
• Diffuse large B-cell lymphoma and prevention of treatment-related heart problems

This research combines efforts to improve cancer control while also considering safety, quality of life, and the balance between treatment benefit and burden.

Clinical studies in this area include research on infertility and reproductive health, with the goal of improving diagnostic and treatment pathways for women trying to conceive. The work also reflects interest in practical interventions that may support better fertility-related care in everyday clinical settings.

• Infertility and evaluation of fertility-related procedures
• Research aimed at improving the chances of conception leading to live birth
• Comparing approaches that may help guide reproductive care more effectively

At Ziekenhuis Amstelland, this field adds a reproductive health dimension to a portfolio that is otherwise strongly centered on cardiovascular and cancer research.

The hematology research portfolio includes studies in multiple myeloma and diffuse large B-cell lymphoma. These trials are focused on improving disease control, exploring treatment sequencing, and reducing complications from therapy, especially when patients need effective treatment over a longer period.

• Multiple myeloma and strategies for treatment-free intervals
• DLBCL and prevention of heart damage linked to cancer therapy
• Evaluating whether treatment approaches can preserve effectiveness while limiting toxicity

This area shows a clear interest in balancing cancer treatment benefit with safety, particularly in patients who may already face elevated cardiovascular risk.